Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Islet Transplantation in Type 1 Diabetic Patients Using the UIC Protocol, Phase 3

NCT00679042 is registered in ClinicalTrials.gov with CellTrans Inc. as lead sponsor.

NCT NCT00679042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00679042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Islet Transplantation in Type 1 Diabetic Patients Using the UIC Protocol, Phase 3
Lead sponsor
CellTrans Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
September 5, 2007
Completion date
June 14, 2026
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus